Bend Research open to outside collaboration

Bend Research, an Oregon, USA-based firm specializing in the definition, advancement, development and commercialization of pharmaceutical and health science technologies, says that it will now independently offer its drug-delivery expertise and technologies to outside firms.

Bend will continue its 23-year collaboration with global drug behemoth Pfizer, but will also be free to work with other pharmaceutical and biotechnology companies using proprietary technologies developed jointly by the two firms. These include optimized drug discovery, dosage form development, engineering capabilities and the manufacture of supplies for clinical trials under Good Manufacturing Practice standards.

Chief executive, Rod Ray, said: "our work with Pfizer has helped us tremendously to grow and develop our capabilities over the past two decades. In return, we have helped Pfizer advance a significant number of their compounds. Today, we're pleased to have the opportunity to collaborate with additional clients to enable the delivery of new medicines."